Effect of carbon tetra chloride (CCL4) on transforming growth factor -beta (TGF-β) expression in chronic liver disease.

Tammam, Omar Y.; Elrehany, Mahmoud A.; Abo-Aziza, Faten A.M.; Gaber, Shereen S.; Bayoumi, Asmaa M.A.

doi:10.21608/mjmr.2021.237749

	Effect of carbon tetra chloride (CCL4) on transforming growth factor -beta (TGF-β) expression in chronic liver disease.
Minia Journal of Medical Research
Volume 32, Issue 3, July 2021, Page 1-3 PDF (303.92 K)
Document Type: Original Article
DOI: 10.21608/mjmr.2021.237749
View on SCiNiTO
Authors
Omar Y. Tammam¹; Mahmoud A. Elrehany²; Faten A.M. Abo-Aziza³; Shereen S. Gaber⁴; Asmaa M.A. Bayoumi¹
¹Department of biochemistry, faculty of pharmacy, Deraya University, Minia, Egypt
²Department of biochemistry, faculty of pharmacy, Deraya University, Minia, Egypt ** Department of biochemistry, faculty of medicine, Minia University, Minia, Egypt
³Department of Parasitology and Animal Diseases, Veterinary Research Division, National Research Center, Giza, Egypt.
⁴Department of biochemistry, faculty of medicine, Minia University, Minia, Egypt
Abstract
Background: The liver is one of the most important organs in the human body because of its utmost importance, and it plays many essential roles for the body. Carbon tetrachloride affects the body in general and the liver, which sometimes leads to the occurrence of chronic hepatitis and may reach its climax and cause fibrosis. One of the effects of carbon tetrachloride is the stimulation of the beta-TGF pathway. Results: After CCL4 administration; There is highly statistically significant difference in expression level of TGF-β (p < 0.005). Conclusions: This study shows that carbon tetra chloride is promotor for several liver diseases that occur due to activation and upregulation of TGF-β.
Keywords
CCl4; TGF-β; chronic liver disease


Statistics Article View: 79 PDF Download: 70